HS Wezlana Biosimilar Market Size and Forecast Wezlana (ustekinumab-auub) is a critical biosimilar entry, approved as interchangeable with the blockbuster drug Stelara (ustekinumab), which generated substantial sales, reaching $17 billion in 2024….
AS Spesolimab Market: Size, Forecast, Drivers, and Key Trends
Spesolimab Market Size and Forecast Spesolimab, marketed as Spevigo, targets Generalized Pustular Psoriasis (GPP) flares, a rare and severe skin condition. As an innovative interleukin-36 receptor antagonist, it addresses a significant unmet…
RA Ifabotuzumab Market: Size, Forecast, Drivers, and Key Trends
RA Ifabotuzumab Market Size and Forecast Ifabotuzumab, as a potential therapy for Rheumatoid Arthritis (RA), targets a specific mechanism of action, positioning it within the highly competitive immunology market. The potential market…
RET Cabozantinib Market: Size, Forecast, Drivers, and Key Trends
RET Cabozantinib Market Size and Forecast Cabozantinib, marketed as Cometriq and Cabometyx, is a multi-tyrosine kinase inhibitor with specific activity against the RET receptor. Its market size is projected for substantial growth,…
NTRK Alt Market: Size, Forecast, Drivers, and Key Trends
NTRK Alt Market Size and Forecast The NTRK fusion-positive advanced solid tumor market is a highly specialized segment within oncology, defined by actionable genomic alterations. Market growth is driven by the efficacy…
MSI Tebotelimab Market: Size, Forecast, Drivers, and Key Trends
MSI-H/dMMR Market Size and Forecast (Relevant to Tebotelimab’s Target) The market for treatments targeting MSI-H/dMMR (Microsatellite Instability-High/deficient Mismatch Repair) cancers is substantial and rapidly expanding. This segment was valued at approximately USD…
BRAF MEK Combo Generics Market: Size, Forecast, Drivers, and Key Trends
BRAF MEK Combo Generics Market Size and Forecast The BRAF MEK combination generics market is anticipated to emerge as branded combination therapies, such as Tafinlar and Mekinist, face patent expiration in the…
ROS1 Crizotinib Legacy Market: Size, Forecast, Drivers, and Key Trends
ROS1 Crizotinib Legacy Market Size and Forecast The ROS1 Crizotinib legacy market refers to the continuing use and economic presence of Crizotinib (XALKORI) as a first-generation targeted therapy for ROS1-fusion positive Non-Small…
ALK Alectinib Generics Market: Size, Forecast, Drivers, and Key Trends
ALK Alectinib Generics Market Size and Forecast The ALK Alectinib generics market is set for significant expansion following the patent expiry of the originator drug, Alecensa, expected around 2035. While the branded…
SCLC Topotecan Market: Size, Forecast, Drivers, and Key Trends
Topotecan in SCLC Market Size and Forecast Topotecan (Hycamtin) holds a steady, though relatively niche, position within the Small Cell Lung Cancer (SCLC) therapeutics market, primarily serving as a second-line or relapsed…